Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

CRISPR genome editing by IDTCRISPR genome editing by IDT
VS
RocheRoche
CRISPR genome editing by IDT

CRISPR genome editing by IDT

1710 Commercial Park, Coralville, 52241, US

Last Update: 16/03/2026

View Profile
Between 750 and 799
http://www.idtdna.com/crispr
753/1000Fair

The clustered regularly interspaced short palindromic repeat (CRISPR) system is an RNA guided genome editing tool that is revolutionizing genome engineering.

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:66
12-month incidents
0
Known data breaches
0
Attack type number
0
Roche

Roche

Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH

Last Update: 28/06/2026

View Profile
Between 800 and 849
http://www.roche.com/
835/1000Good

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:103,689
Subsidiaries:51
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
CRISPR genome editing by IDT

CRISPR genome editing by IDT

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Roche

Roche

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for CRISPR genome editing by IDT in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Roche in 2026.

Incidents

Incident History - CRISPR genome editing by IDT (X = Date, Y = Severity)

CRISPR genome editing by IDT cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Roche (X = Date, Y = Severity)

Roche cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
CRISPR genome editing by IDT

CRISPR genome editing by IDT

Incidents
No explicit notable incidents reported.
Roche

Roche

Incidents
No explicit notable incidents reported.

FAQ

Between CRISPR genome editing by IDT company and Roche company, which one has the best AI Cybersecurity Score ?
Between CRISPR genome editing by IDT company and Roche company, which one has experienced more cyber incidents in the past ?
Between CRISPR genome editing by IDT company and Roche company, which one has experienced more cyber incidents this year ?
Between CRISPR genome editing by IDT company and Roche company, which one has experienced at least one ransomware attack ?
Between CRISPR genome editing by IDT company and Roche company, which one has experienced at least one data breach ?
Between CRISPR genome editing by IDT company and Roche company, which one has experienced at least one targeted cyberattack ?
Between CRISPR genome editing by IDT company and Roche company, which one has experienced at least one vulnerability ?
Between CRISPR genome editing by IDT company and Roche company, which one holds the most compliance certifications ?
Between CRISPR genome editing by IDT company and Roche company, which one holds the fewest compliance certifications ?
Between CRISPR genome editing by IDT company and Roche company, which one has the most subsidiaries ?
Between CRISPR genome editing by IDT company and Roche company, which one has the largest number of employees ?
Between CRISPR genome editing by IDT and Roche, which company holds both SOC 2 Type 1 certifications ?
Between CRISPR genome editing by IDT and Roche, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - CRISPR genome editing by IDT or Roche ?
Which company is PCI DSS compliant - CRISPR genome editing by IDT or Roche ?
Between CRISPR genome editing by IDT and Roche, which company complies with HIPAA regulations for healthcare data ?
Between CRISPR genome editing by IDT and Roche, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9